Physician profile
Jane R Schwebke
NPI 1124040225
$41,845.91
in general payments reported to CMS, 2019-2025
5 companies · $2,000 in 2025
The $2,000 reported for 2025 was more than what 85% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,651 · 2020: $2,450 · 2021: $500 · 2023: $24K · 2024: $7,281 · 2025: $2,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $12K · Honoraria: $817 · Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,395.00 |
| Travel and Lodging | $12,367.95 |
| Honoraria | $817.30 |
| Food and Beverage | $665.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gen-Probe, INC. | $25,228.80 | 2019-2025 | Aptima, None, Panther Fusion |
| Hologic Sales and Service, LLC | $12,573.41 | 2023-2024 | Aptima |
| Gen-Probe Sales & Service, INC. | $3,567.23 | 2019 | |
| Amag Pharmaceuticals, INC. | $450.00 | 2020 | |
| Lupin INC. | $26.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Schwebke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.